|
Forecast Period
|
2026-2030
|
|
Market Size (2024)
|
USD 245.48 Million
|
|
Market Size (2030)
|
USD 330.59 Million
|
|
CAGR (2025-2030)
|
5.19%
|
|
Fastest Growing Segment
|
Companion Animal
|
|
Largest Market
|
North India
|
Market Overview
India Animal Vaccine Market was valued at USD 245.48 Million in 2024 and is anticipated to reach USD 330.59 Million by 2030, with a CAGR of 5.19% during 2025-2030.
This vital industry focuses on the research, production, and distribution of vaccines that protect animal health. These veterinary biologics are indispensable for safeguarding both livestock and companion animals, playing a crucial role in preventing infectious disease outbreaks and ensuring the well-being of India's diverse animal populations.
A primary catalyst for this market growth is the increasing public awareness of animal health and its connection to human safety. As consciousness about zoonotic diseases rises, the demand for preventive measures like vaccination intensifies. In response, governmental bodies are launching proactive initiatives to bolster animal healthcare infrastructure. These policies aim to improve the accessibility and distribution of essential vaccines, thereby strengthening disease control efforts for both commercial livestock and household pets, which in turn supports a healthier public environment for all.
Furthermore, continuous advancements in biotechnology are revolutionizing the development and efficacy of animal vaccines. Cutting-edge methods, including genetic engineering and recombinant DNA technology, are at the forefront of this innovation. These sophisticated techniques enable the creation of highly targeted vaccines that can elicit a powerful and specific immune response against pathogens. This scientific progress not only enhances the effectiveness and safety of modern vaccines but also streamlines the development of new solutions to combat emerging and persistent animal diseases effectively.
Key Market Drivers
Rising Livestock Disease Incidence
The rising incidence and continuing threat of livestock diseases in India is a major driver of animal vaccine demand because the country has an exceptionally large and dense animal base, with the 20th Livestock Census reporting 536.76 million livestock, including 303.76 million bovines, along with 851.81 million poultry, which creates ideal conditions for rapid disease transmission and makes preventive immunization far more practical than outbreak response alone.
This is especially important in a country where animal health is directly tied to milk, egg, and meat supply as well as rural incomes, and the government has explicitly linked vaccination with higher livestock productivity by noting under the National Animal Disease Control Programme that immunization helps reduce disease burden and improve output.
The scale of official vaccination activity itself reflects how serious the disease challenge has become, with the government stating in August 2024 that around 82 crore cumulative foot and mouth disease vaccinations had been carried out and that the programme had already completed Round 4 in 21 states, while brucellosis remains part of the same flagship national disease control effort.
Other outbreaks continue to reinforce vaccine urgency, as WHO recorded a human infection with avian influenza A H9N2 in West Bengal in 2024 and the government has separately noted that lumpy skin disease spread across multiple states and caused heavy production losses and mortality in cattle, prompting accelerated vaccine development and state support.
For instance, CARE Ratings says Hester Biosciences is one of the largest poultry vaccine manufacturers in India, the country’s largest manufacturer of PPR vaccine and Goat Pox vaccine, and has animal vaccine manufacturing capacity of 13.90 billion doses per annum, clearly showing how large manufacturers are scaling supply in response to India’s persistent livestock disease burden and rising demand for preventive vaccination.
Growing Global Pet Adoption
The growing culture of pet ownership and responsible companion animal care is significantly increasing demand for animal vaccines in India, because more households, shelters, and veterinary providers now treat routine immunization as a basic part of preventive healthcare for dogs and cats rather than an optional expense.
The need is especially large in the canine segment, as a Government of India written reply based on the 2019 livestock census reported 153 lakh stray dogs in the country, while the Animal Birth Control Rules 2023 require local bodies to carry out sterilisation and immunization of stray dogs, showing that India’s vaccine need extends across both owned pets and free roaming dog populations.
This wider preventive approach has become more important as awareness of rabies and other zoonotic risks has strengthened, and the Animal Welfare Board of India stated in its 2023 to 2024 annual report that it continues to implement the central sector scheme for sterilisation and immunization of stray dogs while providing Rs. 450.43 lakh in financial assistance to 277 NGOs, animal welfare organisations, SPCAs, and gaushalas, reinforcing vaccine deployment through institutional channels. The market is also being shaped by stronger organized supply from major vaccine makers that are expanding access and visibility for companion animal immunization in India.
For instance, Indian Immunologicals said it is the largest producer of both human and animal anti rabies vaccines in the country with 70 percent share in the animal anti rabies trade market, exports to 50 countries, and pledged 5 lakh doses of veterinary anti rabies vaccine for free roaming dogs, which clearly shows how large established players are responding to India’s rising companion animal and canine public health vaccination needs.
Key Industry and Government Initiatives
Government agencies, animal health institutions, and major vaccine manufacturers are playing a pivotal role in boosting demand for animal vaccines in India by turning preventive immunization into a large, organized, and recurring part of livestock and companion animal healthcare rather than a reactive response to outbreaks.
The National Animal Disease Control Programme was launched as a flagship nationwide scheme to control foot and mouth disease and brucellosis by vaccinating 100 percent of cattle, buffalo, sheep, goat, and pig populations for FMD and 100 percent of bovine female calves between 4 and 8 months for brucellosis, with a total outlay of Rs. 13,343 crore for five years, which has created a strong and sustained institutional base for vaccine demand across states.
The scale of this push is already visible, as the government said that up to 2024 around 4.4 crore female calves had been cumulatively vaccinated under NADCP and, in a separate update, that roughly 82 crore cumulative FMD vaccinations had been carried out, showing how public programmes are directly translating policy into very large vaccine volumes on the ground.
Support is also reinforced by animal welfare and public health frameworks, with the Animal Birth Control Rules 2023 mandating sterilisation and immunization of stray dogs and the Animal Welfare Board of India reporting financial assistance of Rs. 450.43 lakh in 2023 to 2024 to 277 NGOs, SPCAs, and animal welfare organizations, which helps widen awareness and vaccination coverage beyond farm animals alone.
Private sector leaders are strengthening this ecosystem through product development, manufacturing scale, and distribution reach, ensuring that vaccines are available for poultry, cattle, small ruminants, and companion animals across India’s diverse veterinary market.
Expansion of Animal Husbandry
The continuous expansion of animal husbandry in India is a significant driver for the animal vaccine market because rising demand for milk, meat, and eggs is pushing farmers to maintain and expand larger livestock populations, which in turn raises the risk of disease transmission and makes preventive vaccination an essential operating practice rather than a discretionary expense.
The 20th Livestock Census showed that India’s total livestock population reached 535.78 million in 2019, up 4.6 percent over the previous census, while poultry rose to 851.81 million, a scale that highlights both the growing economic importance of animal husbandry and the biological vulnerability that comes with dense animal populations across farms and supply chains.
Vaccination is increasingly viewed as a cost effective safeguard because outbreaks of diseases such as foot and mouth disease and brucellosis can sharply reduce productivity, weaken farmer incomes, and disrupt food supply continuity, which is why the National Animal Disease Control Programme was designed to vaccinate 100 percent of cattle, buffalo, sheep, goat, and pig populations for FMD and 100 percent of bovine female calves between 4 and 8 months for brucellosis under a central outlay of Rs. 13,343 crore.
This large institutional push reinforces vaccine demand not only through direct public procurement but also by embedding disease prevention into the everyday economics of animal rearing, especially as vaccination is linked to better productivity, lower mortality, and more stable farm returns.
For instance, CARE Ratings says Hester Biosciences is one of India’s largest poultry vaccine manufacturers, the country’s largest manufacturer of PPR vaccine and Goat Pox vaccine, and had animal vaccine manufacturing capacity of 13.90 billion doses per annum, which clearly shows how leading companies are scaling supply in response to the growth of India’s livestock economy and the rising importance of preventive animal healthcare.
Download Free Sample Report
Key Market Challenges
High Vaccine Storage Costs
High storage costs represent a significant restraint on the Indian animal vaccine market. Maintaining vaccine efficacy is critically dependent on a consistent cold chain, but the required infrastructure is expensive. In many rural areas, unreliable electricity and frequent power outages threaten the stability of refrigeration. This makes it difficult to store vaccines at the required temperatures, risking spoilage and rendering them ineffective. The cost of backup power solutions like generators or solar-powered refrigerators is often prohibitively high for individual farmers and small veterinary clinics.
The financial burden of specialized storage facilities further suppresses vaccine demand. Establishing and maintaining cold rooms and dedicated vaccine refrigeration units requires a substantial initial investment and ongoing operational costs. For the millions of small-scale farmers who form the backbone of India's livestock sector, these expenses are often unattainable. This lack of accessible and affordable cold chain infrastructure directly limits the purchase and use of vaccines, creating a major barrier to widespread disease prevention efforts in the country's agricultural heartlands.
Shortage of Skilled Professionals
A critical shortage of qualified veterinarians and skilled farm workers is hampering the demand for animal vaccines in India. Effective vaccination programs depend on the expertise of trained professionals to ensure proper administration, dosages, and scheduling. Without sufficient access to veterinary guidance, many farmers remain unaware of the importance of vaccinations or lack the knowledge to administer them correctly. This information gap leads to improper handling, reduced vaccine efficacy, and a general reluctance to invest in preventive healthcare for their livestock.
The scarcity of skilled farm labor also poses a significant challenge, particularly for implementing large-scale vaccination campaigns. Administering vaccines to large herds or flocks is a labor-intensive process that requires trained assistance. Furthermore, the cost associated with hiring veterinary services can be a major financial barrier for small and marginal farmers. This combination of limited professional access and affordability issues directly contributes to lower vaccination rates, hindering efforts to control animal diseases and protect agricultural productivity across India.
Key Market Trends
Government Initiatives
Proactive government initiatives are a major driver for the Indian animal vaccine market. Through comprehensive disease surveillance, mass vaccination programs, and public awareness campaigns, the government has been instrumental in safeguarding animal health. These concerted efforts, aimed at controlling and eradicating diseases like FMD, directly stimulate demand for vaccines. By prioritizing animal welfare and implementing preventative strategies, these programs create a stable environment for growth in the animal husbandry and veterinary sectors, bolstering the rural economy and ensuring a secure food supply chain.
The government's commitment extends to fostering research and innovation in animal healthcare. By investing in modern research facilities and promoting collaboration between academia, industry, and state agencies, India is cultivating an ecosystem for advanced veterinary science. This focus on technological adoption and skill development has improved the quality of animal care and positioned India as an emerging leader in the global veterinary market. These advancements attract investment, generate employment, and drive the socio-economic development of the nation's agricultural sector.
Technological Advancements
Recent technological advancements are revolutionizing the animal vaccine market by enabling the development of more efficient and targeted vaccines. Innovations using artificial intelligence (AI) and big data analytics are accelerating research and development, significantly improving vaccine efficacy. By analyzing vast datasets on pathogens and immune responses, scientists can design next-generation vaccines faster than ever before. This technological leap is ushering in a new era of proactive disease prevention, protecting animal populations from both existing and emerging health threats.
The impact of this accelerated vaccine development is profound, allowing for rapid responses to disease outbreaks and strengthening public health security. The ability to create and deploy highly effective vaccines quickly helps contain the spread of infectious diseases, including those with zoonotic potential. This paradigm shift empowers veterinary systems to manage health crises more effectively and protect the agricultural economy from the devastating impact of animal pandemics. As these technologies mature, they promise a future of enhanced global health and more resilient food systems.
Segmental Insights
Animal Type Insights
The poultry segment is projected to dominate the Indian animal vaccine market, driven by the nation's substantial and growing consumption of poultry products. As an essential source of protein for a large population, poultry flocks' health is directly linked to food safety and public health. The rapid, exponential growth of the poultry industry to meet this rising demand amplifies the need for effective vaccination programs. Consequently, disease prevention in this sector is not merely an agricultural priority but a critical component of national food security.
This market leadership is also supported by a notable increase in health awareness among poultry farmers. Modern producers understand that proactive, preventive healthcare is essential for maintaining flock productivity and ensuring profitability. They are actively seeking reliable vaccines to protect their birds from costly diseases, viewing vaccination as a crucial investment in their business's sustainability. This combination of high consumption, industry growth, and farmer awareness creates sustained, robust demand for advanced poultry vaccines in the Indian market.
Technology Insights
In terms of technology, recombinant vaccines are poised to lead the Indian market due to their superior design and efficacy. This advanced technology uses recombinant DNA to introduce one or more specific genes into an animal's cells, thereby stimulating a stronger, more targeted immune response. This precision enables the creation of vaccines that are highly effective against specific pathogens. As a result of this well-defined, controlled development process, recombinant vaccines offer greater efficiency and a safer profile than traditional vaccines.
The growing preference for recombinant vaccines among veterinarians is a key factor in their projected market dominance. Professionals are increasingly opting for these solutions due to their reliability and reduced risk of side effects. This trend is amplified by the rising prevalence of complex animal diseases and a greater public understanding of animal health needs. As demand for high-quality veterinary care increases with pet ownership and livestock intensification, recombinant vaccines provide an innovative and effective tool to enhance animal welfare and disease control.
Download Free Sample Report
Regional Insights
The North region of India is poised to dominate the national animal vaccine market, a leadership position attributed to its significant concentration of livestock and poultry farms. States in this region have a deep-rooted agricultural history, supporting a thriving industry where animal health is paramount. The high density of animal populations creates a substantial and consistent demand for vaccines to prevent and control disease outbreaks. This established agricultural infrastructure makes North India a critical hub for vaccine consumption and market growth.
A growing awareness among farmers and animal health professionals regarding the importance of vaccination further solidifies North India's market lead. Farmers increasingly view vaccines not as a cost but as a crucial investment for protecting animal health, boosting productivity, and ensuring farm profitability. This change is driven by educational initiatives and active promotion by veterinarians who emphasize the economic benefits of preventive healthcare, leading to higher adoption rates for vaccination protocols across the region.
The rising consumer demand for animal-derived food products like meat and milk also fuels the need for effective vaccines in North India. As the population's dietary preferences evolve, farmers must maintain healthy and productive livestock to meet this demand sustainably. Vaccination is essential for ensuring animals meet the stringent quality and safety standards required for food production. This market pull ensures a steady demand for vaccines, cementing the region's role in the future of India's animal health industry.
Recent Developments
- In January 2026, Hester reported that during the quarter it capitalised its fill-finish facility, which it said effectively doubled drug product capacity to support growth across domestic and export markets. Hester also said it received marketing and manufacturing licences for its H9N2 Avian Influenza vaccine, strengthening its poultry vaccine portfolio.
- In January 2026, Indian Immunologicals (IIL) announced a pledge of 5 lakh doses of veterinary anti-rabies vaccine for free-roaming dogs under its CSR programme.
- In September 2025, IIL rolled out Raksha‑IBR, described as India’s first indigenously developed gE-deleted DIVA marker vaccine against infectious bovine rhinotracheitis (IBR). The marker/DIVA approach is positioned to help differentiate infected animals from vaccinated animals.
- In September 2025, India's leading veterinary vaccine manufacturers, including Hester Biosciences and Indian Immunologicals, have established the Veterinary Vaccine India Manufacturers Association (VVIMA). This association aims to foster collaboration with policymakers to address industry needs. The veterinary vaccine market in India is currently estimated at ₹2,000 crore (INR 20 billion).
Key Market Players
- Biovet Private Ltd.
- Hester Biosciences
Limited
- Intervet India
Private Limited(Merck Limited)
- Indovax Pvt. Ltd
- Bio-Med (P) Limited
- Zoetis India Ltd.
- Brilliant Bio Pharma
Private Limited
- Virbac Animal Health
India Pvt Ltd
- Elanco India Private
Limited
- Ceva Polychem Private Limited
|
By Animal Type
|
By Technology
|
By Disease
|
By Route of
Administration
|
By Distribution
Channel
|
By Region
|
- Livestock
- Swine
- Poultry
- Companion Animals
- Others
|
- Inactive Vaccine
- Live Attenuated
Vaccine
- Toxoid Vaccine
- Recombinant Vaccine
- Others
|
- Foot and Mouth
Disease
- New Castle Disease
- Infectious Bronchitis
- Infectious Bursal
Disease
- Fowl pox
- Rabies
- Others
|
- Subcutaneous
- Intramuscular
- Intraocular
- Oral
- Others
|
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies
|
|
Report
Scope:
In this
report, the India Animal Vaccine Market has been segmented into the following
categories, in addition to the industry trends which have also been detailed
below:
- India Animal Vaccine Market, By Animal Type:
o
Livestock
o
Swine
o
Poultry
o
Companion Animals
o
Others
- India Animal Vaccine Market, By Technology:
o
Inactive Vaccine
o
Live Attenuated
Vaccine
o
Toxoid Vaccine
o
Recombinant Vaccine
o
Others
- India Animal Vaccine Market, By Disease:
o
Foot and Mouth
Disease
o
New Castle Disease
o
Infectious Bronchitis
o
Infectious Bursal
Disease
o
Fowl pox
o
Rabies
o
Others
- India Animal Vaccine Market, By Route of
Administration:
o
Subcutaneous
o
Intramuscular
o
Intraocular
o
Oral
o
Others
- India Animal Vaccine Market, By Distribution
Channel:
o
Veterinary Hospitals
o
Veterinary Clinics
o
Pharmacies
- India Animal Vaccine
Market, By Region:
o
North
o
South
o
West
o
East
Competitive
Landscape
Company
Profiles: Detailed analysis of the major
companies present in the India Animal Vaccine Market.
Available
Customizations:
India Animal
Vaccine Market report with the given market data, TechSci Research
offers customizations according to a company's specific needs. The following
customization options are available for the report:
Company
Information
- Detailed analysis and profiling of
additional market players (up to five).
India Animal
Vaccine Market is an upcoming report to be released soon. If you wish an early
delivery of this report or want to confirm the date of release, please contact
us at [email protected]